Autologous hematopoietic stem cell transplantation in multiple sclerosis
Article 2015 en
Authors
GM
Gianluigi Mancardi
MS
Maria Pia Sormani
FG
Francesca Gualandi
Abstract
1 min read
Intense immunosuppression followed by AHSCT is significantly superior to MTX in reducing MRI activity in severe cases of MS. These results strongly support further phase III studies with primary clinical endpoints. The study was registered as EUDRACT No. 2007-000064-24.
A. Giordano, Montserrat Rovira, Marisol Veny, Rebeca Barastegui, Pedro Marı́n, Carmen Martı́nez, Francesc Fernández‐Avilés, María Suárez‐Lledó, Ariadna Domènech, Anna Serrahima, Miquel Lozano, Joan Cid, Íngrid Ordás, A Fernández-Clotet, Berta Caballol, Marta Gallego, Alejandro Vara, Maria Carme Masamunt, À Giner, Iris Teubel, Manel Esteller,
Massimo Filippi, D. W. Paty, Ludwig Kappos, Frederik Barkhof, D. A. S. Compston, Alan J. Thompson, G. J. Zhao, C M Wiles, W. I. McDonald, David H. Miller
Discussion(0)
No comments yet. Be the first to comment.